LC-MS metabolomics of psoriasis patients reveals disease severity-dependent increases in circulating amino acids that are ameliorated by anti-TNFα treatment.

LC-MS metabolomics of psoriasis patients reveals disease severity-dependent increases in circulating amino acids that are ameliorated by anti-TNFα treatment.

Item
http://www.wikidata.org/entity/Q34855603
Biomarkers of An Autoimmune Skin Disease--PsoriasisMixing omics: combining genetics and metabolomics to study rheumatic diseases.Circulating levels of sphingosine-1-phosphate are elevated in severe, but not mild psoriasis and are unresponsive to anti-TNF-α treatment.Concurrent profiling of polar metabolites and lipids in human plasma using HILIC-FTMS.The metabolic analysis of psoriasis identifies the associated metabolites while providing computational models for the monitoring of the disease.Metabolomics analysis identifies sex-associated metabotypes of oxidative stress and the autotaxin-lysoPA axis in COPD.Exploration of candidate biomarkers for human psoriasis based on gas chromatography-mass spectrometry serum metabolomics.Untargeted serum metabonomics study of psoriasis vulgaris based on ultra-performance liquid chromatography coupled to mass spectrometry.A simple LC-MS/MS method for quantitative analysis of underivatized neurotransmitters in rats urine: assay development, validation and application in the CUMS rat model.Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints.Differential glucose requirement in skin homeostasis and injury identifies a therapeutic target for psoriasis.Altered peripheral amino acid profile indicate a systemic impact of active celiac disease and a possible role of amino acids in disease pathogenesis.The metabolomics of psoriatic disease.Identifying biomarkers in human psoriasis: revealed by a systems metabolomics approach.
P2860

LC-MS metabolomics of psoriasis patients reveals disease severity-dependent increases in circulating amino acids that are ameliorated by anti-TNFα treatment.

Item
http://www.wikidata.org/entity/Q34855603
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
LC-MS metabolomics of psoriasi ...... orated by anti-TNFα treatment.
@ast
LC-MS metabolomics of psoriasi ...... orated by anti-TNFα treatment.
@en
LC-MS metabolomics of psoriasi ...... orated by anti-TNFα treatment.
@nl
type
label
LC-MS metabolomics of psoriasi ...... orated by anti-TNFα treatment.
@ast
LC-MS metabolomics of psoriasi ...... orated by anti-TNFα treatment.
@en
LC-MS metabolomics of psoriasi ...... orated by anti-TNFα treatment.
@nl
prefLabel
LC-MS metabolomics of psoriasi ...... orated by anti-TNFα treatment.
@ast
LC-MS metabolomics of psoriasi ...... orated by anti-TNFα treatment.
@en
LC-MS metabolomics of psoriasi ...... orated by anti-TNFα treatment.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
LC-MS metabolomics of psoriasi ...... orated by anti-TNFα treatment.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932